compound semaglutide and alcohol Could GLP-1 medications help transform treatment for addiction? Alcohol Use Disorder affects millions, yet there haven't been any new medications approved to treat it in 20 years. Now, new #CUAnschutz research Troubling Findings in Study of

GIP receptor modulation: It assists in insulin release and lipid metabolism, allowing researchers to observe measurable improvements in glucose handling, adipose activity, and overall metabolic responsiveness across study models

A complete setup requires bacteriostatic water for reconstitution, insulin syringes for measurement and administration, alcohol swabs for sterile technique, and appropriate sharps disposal

Hickey WF, Hsu BL, Kimura H

MET-224o, an ultra-long acting GLP-1 RA being developed to be administered at lower dose levels than other oral peptides developed through Metseras Nutrient Stimulated Hormone (NuSH) platform, to improve scalability